Laffer Investments continued to hold its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,815 shares of the medical instruments supplier’s stock at the end of the second quarter. Laffer Investments’ holdings in DENTSPLY SIRONA were worth $1,933,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in XRAY. Canada Pension Plan Investment Board increased its stake in DENTSPLY SIRONA by 109.6% in the first quarter. Canada Pension Plan Investment Board now owns 25,993 shares of the medical instruments supplier’s stock valued at $1,623,000 after purchasing an additional 13,593 shares in the last quarter. Comerica Bank increased its stake in DENTSPLY SIRONA by 2.9% in the first quarter. Comerica Bank now owns 60,531 shares of the medical instruments supplier’s stock valued at $3,842,000 after purchasing an additional 1,734 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in DENTSPLY SIRONA by 4.1% in the first quarter. UBS Asset Management Americas Inc. now owns 1,024,996 shares of the medical instruments supplier’s stock valued at $64,001,000 after purchasing an additional 40,816 shares in the last quarter. CIBC World Markets Inc. bought a new stake in DENTSPLY SIRONA in the first quarter valued at $1,337,000. Finally, Norinchukin Bank The increased its stake in DENTSPLY SIRONA by 11.3% in the first quarter. Norinchukin Bank The now owns 43,901 shares of the medical instruments supplier’s stock valued at $2,741,000 after purchasing an additional 4,448 shares in the last quarter. 93.87% of the stock is owned by institutional investors and hedge funds.

Shares of DENTSPLY SIRONA Inc. (XRAY) traded up 1.45% on Wednesday, hitting $58.69. 285,576 shares of the stock were exchanged. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68. The company has a 50-day moving average price of $56.98 and a 200 day moving average price of $61.67. The company’s market cap is $13.47 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period last year, the business earned $0.76 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.61%. DENTSPLY SIRONA’s payout ratio is -10.09%.

ILLEGAL ACTIVITY WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/20/laffer-investments-has-1933000-position-in-dentsply-sirona-inc-xray.html.

Several equities research analysts have weighed in on XRAY shares. UBS AG reaffirmed a “neutral” rating and issued a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Jefferies Group LLC decreased their price target on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a research note on Wednesday, August 23rd. Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 price target (down from $70.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Finally, Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, August 14th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $65.73.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.